Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Evaluation of mucoadhesive carrier adjuvant: toward an oral anthrax vaccine.

Mangal S, Pawar D, Agrawal U, Jain AK, Vyas SP.

Artif Cells Nanomed Biotechnol. 2014 Feb;42(1):47-57. doi: 10.3109/21691401.2013.769447. Epub 2013 Mar 1.

PMID:
23452384
2.

Development of a novel adjuvanted nasal vaccine: C48/80 associated with chitosan nanoparticles as a path to enhance mucosal immunity.

Bento D, Staats HF, Gonçalves T, Borges O.

Eur J Pharm Biopharm. 2015 Jun;93:149-64. doi: 10.1016/j.ejpb.2015.03.024. Epub 2015 Mar 26.

PMID:
25818119
4.

Mucosal immunization with a novel nanoemulsion-based recombinant anthrax protective antigen vaccine protects against Bacillus anthracis spore challenge.

Bielinska AU, Janczak KW, Landers JJ, Makidon P, Sower LE, Peterson JW, Baker JR Jr.

Infect Immun. 2007 Aug;75(8):4020-9. Epub 2007 May 14.

5.

Surface plasmon resonance measurements of plasma antibody avidity during primary and secondary responses to anthrax protective antigen.

Lynch HE, Stewart SM, Kepler TB, Sempowski GD, Alam SM.

J Immunol Methods. 2014 Feb;404:1-12. doi: 10.1016/j.jim.2013.11.026. Epub 2013 Dec 4.

6.

Induction of protective immunity against lethal anthrax challenge with a patch.

Kenney RT, Yu J, Guebre-Xabier M, Frech SA, Lambert A, Heller BA, Ellingsworth LR, Eyles JE, Williamson ED, Glenn GM.

J Infect Dis. 2004 Aug 15;190(4):774-82. Epub 2004 Jul 13.

7.

A plant based protective antigen [PA(dIV)] vaccine expressed in chloroplasts demonstrates protective immunity in mice against anthrax.

Gorantala J, Grover S, Goel D, Rahi A, Jayadev Magani SK, Chandra S, Bhatnagar R.

Vaccine. 2011 Jun 15;29(27):4521-33. doi: 10.1016/j.vaccine.2011.03.082. Epub 2011 Apr 17.

PMID:
21504775
8.
9.

A CpG-Ficoll Nanoparticle Adjuvant for Anthrax Protective Antigen Enhances Immunogenicity and Provides Single-Immunization Protection against Inhaled Anthrax in Monkeys.

Kachura MA, Hickle C, Kell SA, Sathe A, Calacsan C, Kiwan R, Hall B, Milley R, Ott G, Coffman RL, Kanzler H, Campbell JD.

J Immunol. 2016 Jan 1;196(1):284-97. doi: 10.4049/jimmunol.1501903. Epub 2015 Nov 25.

PMID:
26608924
10.

Increased long-term immunity to Bacillus anthracis protective antigen in mice immunized with a CIA06B-adjuvanted anthrax vaccine.

Wui SR, Han JE, Kim YH, Rhie GE, Lee NG.

Arch Pharm Res. 2013 Apr;36(4):464-71. doi: 10.1007/s12272-013-0034-5. Epub 2013 Feb 26.

PMID:
23440578
11.

Effective mucosal immunity to anthrax: neutralizing antibodies and Th cell responses following nasal immunization with protective antigen.

Boyaka PN, Tafaro A, Fischer R, Leppla SH, Fujihashi K, McGhee JR.

J Immunol. 2003 Jun 1;170(11):5636-43.

12.

A combination of the TLR4 agonist CIA05 and alum promotes the immune responses to Bacillus anthracis protective antigen in mice.

Wui SR, Kim HK, Han JE, Kim JM, Kim YH, Chun JH, Cho YJ, Lee NG.

Int Immunopharmacol. 2011 Sep;11(9):1195-204. doi: 10.1016/j.intimp.2011.03.020. Epub 2011 Apr 12.

PMID:
21492746
13.

Generation of protective immune response against anthrax by oral immunization with protective antigen plant-based vaccine.

Gorantala J, Grover S, Rahi A, Chaudhary P, Rajwanshi R, Sarin NB, Bhatnagar R.

J Biotechnol. 2014 Apr 20;176:1-10. doi: 10.1016/j.jbiotec.2014.01.033. Epub 2014 Feb 15.

PMID:
24548460
14.

Potentiation of an anthrax DNA vaccine with electroporation.

Luxembourg A, Hannaman D, Nolan E, Ellefsen B, Nakamura G, Chau L, Tellez O, Little S, Bernard R.

Vaccine. 2008 Sep 19;26(40):5216-22. doi: 10.1016/j.vaccine.2008.03.064. Epub 2008 Apr 16.

PMID:
18462850
15.

Towards a human oral vaccine for anthrax: the utility of a Salmonella Typhi Ty21a-based prime-boost immunization strategy.

Baillie LW, Rodriguez AL, Moore S, Atkins HS, Feng C, Nataro JP, Pasetti MF.

Vaccine. 2008 Nov 11;26(48):6083-91. doi: 10.1016/j.vaccine.2008.09.010. Epub 2008 Sep 19.

16.

Protection against anthrax by needle-free mucosal immunization with human anthrax vaccine.

Zeng M, Xu Q, Pichichero ME.

Vaccine. 2007 May 4;25(18):3588-94. Epub 2007 Jan 26.

17.

Killed but metabolically active Bacillus anthracis vaccines induce broad and protective immunity against anthrax.

Skoble J, Beaber JW, Gao Y, Lovchik JA, Sower LE, Liu W, Luckett W, Peterson JW, Calendar R, Portnoy DA, Lyons CR, Dubensky TW Jr.

Infect Immun. 2009 Apr;77(4):1649-63. doi: 10.1128/IAI.00530-08. Epub 2009 Jan 21.

18.

Nasal immunization with the mixture of PA63, LF, and a PGA conjugate induced strong antibody responses against all three antigens.

Sloat BR, Shaker DS, Le UM, Cui Z.

FEMS Immunol Med Microbiol. 2008 Mar;52(2):169-79. doi: 10.1111/j.1574-695X.2007.00347.x. Epub 2008 Jan 9.

20.

Ability of ELISA and a toxin neutralization assay to detect changes in immunogenicity of a recombinant Bacillus anthracis protective antigen vaccine upon storage.

Domínguez-Castillo RI, Verma A, Amador-Molina JC, Sirota L, Arciniega JL.

Biologicals. 2013 Mar;41(2):111-4. doi: 10.1016/j.biologicals.2012.10.002. Epub 2012 Nov 6.

PMID:
23137818
Items per page

Supplemental Content

Write to the Help Desk